Huntington's disease is a four-repeat tauopathy with tau nuclear rods

• Published in: Nature medicine Vol. 20; no. 8; pp. 881 - 885
• Main Authors: Fernández-Nogales, Marta, Cabrera, Jorge R, Santos-Galindo, María, Hoozemans, Jeroen J M, Ferrer, Isidro, Rozemuller, Annemieke J M, Hernández, Félix, Avila, Jesús, Lucas, José J
• Format: Journal Article
• Language: English
• Published: New York Nature Publishing Group US 01.08.2014; Nature Publishing Group
• Subjects: 13; 13/51; 14/19; 14/28; 38; 38/109; 38/35; 38/44; 38/77; 38/88; 38/90; 631/378/1689/1558; 64/110; 692/308/1426; 692/420/2489/144; 82/29; Alternative Splicing; Animals; Binding sites; Biomedicine; Brain - pathology; brief-communication; Cancer Research; Chromosomes; Degeneration; Dementia; Dementia disorders; Frontotemporal Dementia - genetics; Gene therapy; Genetic aspects; Health aspects; Humans; Huntington Disease - genetics; Huntington Disease - metabolism; Huntington's chorea; Huntingtons disease; Infectious Diseases; Metabolic Diseases; Mice; Mice, Knockout; Mice, Transgenic; Molecular Medicine; Mutation; Nervous system; Neurosciences; Nuclear Proteins - genetics; Nuclear Proteins - metabolism; Parkinson's disease; Phosphoproteins - genetics; Phosphoproteins - metabolism; Physiological aspects; Protein Isoforms - genetics; RNA, Messenger - genetics; RNA-Binding Proteins - genetics; RNA-Binding Proteins - metabolism; Rodents; Serine-Arginine Splicing Factors; Serotonin Plasma Membrane Transport Proteins - genetics; tau Proteins - genetics; tau Proteins - metabolism; tau Proteins - ultrastructure; Tauopathies - genetics; Tauopathies - metabolism; Transgenic animals; Netherlands; Spain

Tau pathology is identified in brains of individuals with Huntington's disease (HD), and reduction of tau expression can ameliorate disease in HD model mice. An imbalance of tau isoforms containing either three or four microtubule-binding repeats causes frontotemporal dementia with parkinsonism...